Response to: ‘Comments on the article: "Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial"’ by Mousavi and Taherifard
Open Access
- 10 April 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 81 (3), e47
- https://doi.org/10.1136/annrheumdis-2020-217323
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Comments on the article: “Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial”Annals Of The Rheumatic Diseases, 2020
- Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trialAnnals Of The Rheumatic Diseases, 2019
- Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapseAnnals Of The Rheumatic Diseases, 2019
- Predicting flares in patients with stable systemic lupus erythematosusSeminars in Arthritis and Rheumatism, 2019
- Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategiesMediterranean Journal of Rheumatology, 2017
- Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab TrialsArthritis & Rheumatism, 2013
- Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2007
- The effect of moderate‐dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: Findings of a prospective, randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2006